Trial NCT02047500

View at ClinicalTrials.gov 
Org. Study IDs: EMR200592-006

Last trial update was posted on 2017-12-15

MeSH Interventions

Gemcitabine Paclitaxel

MeSH Conditions

Pancreatic Neoplasms

Other Conditions

Pancreatic Cancer

Stopping Reasons

The trial has been terminated earlier following the company decision to discontinue the clinical development of Evofosfamide

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID